Cargando…

Altered Biological Potential and Radioresponse of Murine Tumors in Different Microenvironments

PURPOSE: This study was conducted to evaluate the biological features of murine hepatocarcinoma according to different tumor microenvironmental models and to determine the change in molecular and immunologic responses after radiation. MATERIALS AND METHODS: Tumor models were established in the liver...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Ik Jae, Lee, Eun Jeong, Park, Hyojin, Kim, Wonwoo, Ha, Sang-Jun, Shin, You Keun, Seong, Jinsil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Cancer Association 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4843754/ https://www.ncbi.nlm.nih.gov/pubmed/26323643 http://dx.doi.org/10.4143/crt.2014.350

Ejemplares similares

Radiation-Induced CXCL12 Upregulation via Histone Modification at the Promoter in the Tumor Microenvironment of Hepatocellular Carcinoma
por: Ahn, Hak Jun, et al.
Publicado: (2019)

Combination of macrophage inflammatory protein 1 alpha with existing therapies to enhance the antitumor effects on murine hepatoma
por: Jeong, Keun-Yeong, et al.
Publicado: (2015)

Characterization of the radioresponse of human apical papilla-derived cells
por: Abe, Shigehiro, et al.
Publicado: (2011)

Characterizing the Radioresponse of Pluripotent and Multipotent Human Stem Cells
por: Lan, Mary L., et al.
Publicado: (2012)

Pathophysiological mechanisms underlying phenotypic differences in pulmonary radioresponse
por: Jackson, Isabel L., et al.
Publicado: (2016)

Corrigendum: Pathophysiological mechanisms underlying phenotypic differences in pulmonary radioresponse
por: Jackson, Isabel L., et al.
Publicado: (2017)

Tumor Growth Suppression and Enhanced Radioresponse by an Exogenous Epidermal Growth Factor in Mouse Xenograft Models with A431 Cells
por: Lim, Yu Jin, et al.
Publicado: (2015)

StemRegenin 1 Mitigates Radiation-Mediated Hematopoietic Injury by Modulating Radioresponse of Hematopoietic Stem/Progenitor Cells
por: Hwang, You Jung, et al.
Publicado: (2023)

Inhibition of IL-17A Suppresses Enhanced-Tumor Growth in Low Dose Pre-Irradiated Tumor Beds
por: Lee, Eun-Jung, et al.
Publicado: (2014)

Identifying key mutations of radioresponsive genes in esophageal squamous cell carcinoma
por: Xu, Xin, et al.
Publicado: (2022)

The Optimal Selection of Radiotherapy Treatment for Hepatocellular Carcinoma
por: Lee, Ik Jae, et al.
Publicado: (2012)

Exploring Nitric Oxide (NO)-Releasing Celecoxib Derivatives as Modulators of Radioresponse in Pheochromocytoma Cells
por: Brandt, Florian, et al.
Publicado: (2022)

A novel 3D pillar/well array platform using patient-derived head and neck tumor to predict the individual radioresponse
por: Lee, Dong Woo, et al.
Publicado: (2022)

Establishment of a 3D Model to Characterize the Radioresponse of Patient-Derived Glioblastoma Cells
por: Strand, Zoe, et al.
Publicado: (2023)

Recombinant human endostatin enhances the radioresponse in esophageal squamous cell carcinoma by normalizing tumor vasculature and reducing hypoxia
por: Zhu, Hongcheng, et al.
Publicado: (2015)

Chronic hypoxia modulates tumour cell radioresponse through cytokine-inducible nitric oxide synthase
por: Berge, D L Van den, et al.
Publicado: (2001)

Autophagy inhibition radiosensitizes in vitro, yet reduces radioresponses in vivo due to deficient immunogenic signalling
por: Ko, A, et al.
Publicado: (2014)

Identifying Long Non-coding RNA of Prostate Cancer Associated With Radioresponse by Comprehensive Bioinformatics Analysis
por: Xu, Meng, et al.
Publicado: (2020)

Fluctuation in radioresponse of HeLa cells during the cell cycle evaluated based on micronucleus frequency
por: Shimono, Hiroaki, et al.
Publicado: (2020)

Radiation improves antitumor effect of immune checkpoint inhibitor in murine hepatocellular carcinoma model
por: Kim, Kyoung-Jin, et al.
Publicado: (2017)

Design, Synthesis and Biological Evaluation of Novel MDH Inhibitors Targeting Tumor Microenvironment
por: Godesi, Sreenivasulu, et al.
Publicado: (2023)

Involvement of metformin and AMPK in the radioresponse and prognosis of luminal versus basal-like breast cancer treated with radiotherapy
por: Zhang, Yimin, et al.
Publicado: (2014)

Neoadjuvant olaparib targets hypoxia to improve radioresponse in a homologous recombination-proficient breast cancer model
por: Borst, Gerben R., et al.
Publicado: (2017)

Effect of Oral Supplementation with Branched-chain Amino Acid (BCAA) during Radiotherapy in Patients with Hepatocellular Carcinoma: A Double-Blind Randomized Study
por: Lee, Ik Jae, et al.
Publicado: (2011)

Correction: Neoadjuvant olaparib targets hypoxia to improve radioresponse in a homologous recombination-proficient breast cancer model
por: Borst, Gerben R., et al.
Publicado: (2020)

Danshensu, a major water-soluble component of Salvia miltiorrhiza, enhances the radioresponse for Lewis Lung Carcinoma xenografts in mice
por: Cao, Hong-Ying, et al.
Publicado: (2017)

Unique epigenetic influence of H2AX phosphorylation and H3K56 acetylation on normal stem cell radioresponses
por: Jacobs, Keith M., et al.
Publicado: (2016)

A Radioresponse-Related lncRNA Biomarker Signature for Risk Classification and Prognosis Prediction in Non-Small-Cell Lung Cancer
por: Song, Jiahang, et al.
Publicado: (2021)

Feasibility of Sorafenib Combined with Local Radiotherapy in Advanced Hepatocellular Carcinoma
por: Cha, Jihye, et al.
Publicado: (2013)

High dose and compartmental target volume may improve patient outcome after radiotherapy for pelvic bone metastases from hepatocellular carcinoma
por: Kim, Taehyung, et al.
Publicado: (2016)

NF-κB inhibition impairs the radioresponse of hypoxic EMT-6 tumour cells through downregulation of inducible nitric oxide synthase
por: Ridder, M De, et al.
Publicado: (2003)

Phase I dose-escalation study of helical intensity-modulated radiotherapy-based stereotactic body radiotherapy for hepatocellular carcinoma
por: Kim, Jun Won, et al.
Publicado: (2016)

Helical tomotherapy for spine oligometastases from gastrointestinal malignancies
por: Choi, Yunseon, et al.
Publicado: (2011)

Clinical factors related to recurrence after hepatic arterial concurrent chemoradiotherapy for advanced but liver-confined hepatocellular carcinoma
por: Cha, Hyejung, et al.
Publicado: (2013)

Clinical Benefit of Hepatic Arterial Infusion Concurrent Chemoradiotherapy in Locally Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
por: Yoon, Hong In, et al.
Publicado: (2016)

Disease-microenvironment modulation by bare- or engineered-exosome for rheumatoid arthritis treatment
por: Lee, Eun Sook, et al.
Publicado: (2023)

Extracellular Matrix Revisited: Roles in Tissue Engineering
por: Kim, Youhwan, et al.
Publicado: (2016)

Extracellular Matrix Revisited: Roles in Tissue Engineering
por: Kim, Youhwan, et al.
Publicado: (2016)

Radiation Inhibits Interleukin-12 Production via Inhibition of C-Rel through the Interleukin-6/ Signal Transducer and Activator of Transcription 3 Signaling Pathway in Dendritic Cells
por: Lee, Eun-Jung, et al.
Publicado: (2016)

Multi-analyte analysis of cytokines that predict outcomes in patients with hepatocellular carcinoma treated with radiotherapy
por: Cha, Hyejung, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_3tn9mht4obgja90hf7lt9bos43